Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Aflibercept injection 8 mg/0.07 mL pre-filled syringe |
| Hydroxocobalamin injection (SAS) 5 mg/mL |
| Hydroxocobalamin oral liquid (QH-CP) 5 mg/mL |
| Phenylephrine injection 0.5 mg/5 mL (0.01%), ampoule |
| Romosozumab injection 105 mg/1.17 mL |
| Sodium hyaluronate intraocular injection “Healon GV Pro” 18 mg/mL, 0.85 mL |
Amendments
| Budesonide inhalation solution 1 mg/2 mL, 500 microgram/2 mL |
| Hydrogen peroxide solution 3% |
| Hydrogen peroxide solution 6% |
| Midazolam injection 15 mg/3 mL, 50 mg/10 mL |
| Phenylephrine injection 10 mg/mL (1%) |
Deletions
| Sodium hyaluronate intraocular injection "Healon" |
| Sodium hyaluronate intraocular injection (M.W.=5,000,000) "Healon GV" 14 mg/mL, 0.55mL |
